AI in Pharma Adoption, Part 5: AI Value in Complex, Unstructured and Multiparametric Data

By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team AI is a combination of statistics, math, algorithms and software able to establish links between the complexity of reality and the emergence of specific behaviors created by the intricate relationships of the studied units. The human body is maybe … Read More